Initial analysis of Pro-Qura: A multi-institutional database of prostate brachytherapy dosimetry

Brachytherapy

Volumn 6, Issue 1, 2007, Pages 9-15

  Merrick, Gregory S ^a,b   Grimm, Peter D ^c,d   Sylvester, John ^c,d   Blasko, John C ^c,d   Butler, Wayne M ^a,b   Allen, Zachariah A ^a,b   Chaudhry, Usman Ul Haq ^a   Mazza, Anthony ^a,b   Sitter, Mike ^c,d  

^a WHEELING HOSPITAL   (United States)

^b WHEELING JESUIT UNIVERSITY   (United States)

^c Seattle Prostate Institute   (United States)

^d ProQura   (United States)

Author keywords

Dosimetry; I 125; Pd 103; Prostate brachytherapy; Quality

Indexed keywords

IODINE 125; PALLADIUM 103; RADIOISOTOPE;

ANALYTIC METHOD; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DOSIMETRY; HUMAN; INSTITUTIONAL CARE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; STANDARDIZATION; STATISTICAL ANALYSIS; ULTRASOUND THERAPY;

BRACHYTHERAPY; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; MALE; PALLADIUM; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY DOSAGE;

EID: 33846617687     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2006.10.002     Document Type: Article

References (15)

1. Merrick G.S., Wallner K.E., and Butler W.M. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol 169 (2003) 1643-1652
2. Stock R.G., Stone R.N., Tabert A., et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41 (1998) 101-108
3. Kollmeier M.A., Stock R.G., and Stone N. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys 57 (2003) 645-653
4. Potters L., Huang D., Calugaru E., et al. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urol 62 (2003) 1073-1077
5. Merrick G.S., Wallner K.E., and Butler W.M. Minimizing prostate brachytherapy-related morbidity. Urology (Review) 62 (2003) 786-792
6. Lee W.R., DeGuzman A.F., Bare R.L., et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: Evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 46 (2000) 83-88
7. Merrick G.S., Butler W.M., Wallner K.E., et al. Variability of prostate brachytherapy preimplant dosimetry: A multi-institutional analysis. Brachytherapy 4 (2005) 241-251
8. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46 (2000) 221-230
9. Mettlin C. Changes in patterns of prostate cancer care in the United States: Results of an American College of Surgeons Commission on Cancer Studies, 1974-1993. Prostate 32 (1997) 221-226
10. Hanks G.E., Krall J.M., Hanlon E.L., et al. Patterns of care and RTOG studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cure. Int J Radiat Oncol Biol Phys 28 (1993) 39-45
11. McNeely L.K., Stone N.N., Presser J., et al. Influence of prostate volume on dosimetry results in real-time 125I seed implantation. Int J Radiat Oncol Biol Phys 58 (2004) 292-299
12. Bice W.S., Prestidge B.R., Grimm P.D., et al. Centralized multi-institutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 41 (1998) 921-927
13. Lee W.R., Roach M., Michalski J., et al. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys 45 (2002) 457-461
14. Han B.H., Wallner K.E., Merrick G.S., et al. The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters. Med Phys 30 (2003) 1096-1102
15. Merrick G.S., Butler W.M., Dorsey A.T., and Lief J.H. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 44 (1999) 1111-1117